MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
SFA Disease: The Lay of the Land
How anatomical challenges affect device choices for revascularization.
By Subhash Banerjee, MD, and Tony S. Das, MD
Tackling Popliteal Artery Lesions
Today's devices enable lesion-specific care tailored to each patient.
By Subhash Banerjee, MD; Emmanouil S. Brilakis, MD, PhD; and Tony S. Das, MD
Covered Stents for the Treatment of SFA Occlusive Disease
A case-based discussion of stent graft use in this challenging anatomy.
IVUS-Guided Femoropopliteal CTO Intervention
A case-based discussion of the role of IVUS in the evolving landscape of complex peripheral interventions.
By Subhash Banerjee, MD, FACC, FSCAI; Zachary Rosol, MD; and Sameh Sayfo, MD
The COBRA Trial
How will cryotherapy compare to conventional balloon angioplasty in peripheral vascular interventions?
By Sivavasavi Dinakaran, MD; Praveen Mehta, MD; Daniel Tran, MSC; Emmanouil S. Brilakis, MD; Subhash Banerjee, MD; and Tony S. Das, MD
One-Year Results Published for COBRA Study of Boston Scientific's PolarCath Cryoplasty System
October 2, 2012—Subhash Banerjee, MD, et al published results from COBRA, the pilot trial of cryoplasty or conventional balloon postdilation of nitinol stents for revascularization of peripheral arterial segments, in the Journal of the American College of Cardiology (2012;60:1252–1359).
COBRA Supports SFA Treatment With Boston Scientific's PolarCath in Diabetic Patients
November 11, 2011—Boston Scientific Corporation (Natick, MA) announced that Principal Investigator Subhash Banerjee, MD, presented data from the COBRA clinical trial during a late-breaking clinical trial session at the annual Transcatheter Cardiovascular Therapeutics scientific symposium in San Francisco.
BridgePoint Commences Peripheral Chronic Total Occlusion Study
August 3, 2011—BridgePoint Medical, Inc. (Plymouth, MN) announced commencement of the company's PFAST-CTOs (Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions [CTOs]) study. Subhash Banerjee, MD, enrolled the first patient in the PFAST-CTOs study.
Femoropopliteal Artery Stent Thrombosis Evaluated in XLPAD Registry
March 23, 2016—A report from the Excellence in Peripheral Artery Disease (XLPAD) registry evaluating the incidence of stent thrombosis in femoropopliteal artery interventions was published Subhash Banerjee, MD, et al online ahead of print in Circulation: Cardiovascular Interventions.
What’s Your Approach?
By Herb Aronow, MD, MPH, FACC, MSCAI, MSVM
The Ongoing SFA Evaluation
By John R. Laird Jr, MD, and Lawrence A. Garcia, MD
Popliteal Interventions
By Takao Ohki, MD, PhD, Chief Medical Editor
AngioSafe’s Santreva-ATK Endovascular Revascularization Catheter Cleared by FDA
October 2, 2025—AngioSafe announced the company’s emergence from stealth with the FDA 510(k) clearance of its flagship product, the Santreva-ATK endovascular revascularization catheter, which is enabled by its atheroplasty technology platform for the treatment of peripheral artery disease.
Exploring Options in the SFA
By John R. Laird, Jr, MD, Chief Medical Editor
